Farmak International JSC is the
leader among all
pharmaceutical manufacturers presented in Ukraine with more than 90 years
history. Farmak keeps the first position in the Ukrainian pharmaceutical
industry with 16.8% market share between local manufacturers and 6.50% share
of the whole Ukrainian pharmaceutical market.
25% of finished medicines are exported to CIS countries, Baltic States,
Germany, Bulgaria, Poland, Vietnam and Middle Asia etc.
The company's portfolio of products includes more than 130 products which are
applied in different fields of medicine such as: endocrinology, ophthalmology,
contrast media, cardiology, great portfolio of OTC products with accent for
respiratory diseases treatment, etc.
We are open for various
types of cooperation, such as export of our products in-bulk
(unlabeled) and in finished dosage forms, transfer of technologies, in- and
out-licensing, R&D, contract manufacturing and always looking for new
possibilities for cooperation.
In 2010 we have
launched a new aseptic workshop for manufacturing of products in vials, ampoules and
In 2014 new soft
gelatin capsules workshop was launched due to expansion of the company's
In 2015 Farmak has
launched GMP-compliant API synthesis facility in Shostka.
It is a modern complex with manufacturing sites, quality control laboratory,
and logistics center.
Also in 2015 Farmak
has launched into operation a new R&D laboratory and technology
facility in Kyiv. The full cycle
implementation: from development of new medicinal products to the manufacture
of laboratory, pilot, and clinical batches in compliance with GMP requirements
will enable Farmak to produce new science-intensive drugs.
lines are GMP certified by Ukrainian governmental inspection according to
PIC/S and by European authorities from Poland, Croatia and Germany.
In 2013 Farmak JSC was also inspected by US FDA and received FDA's confirmation
of food supplements in solid dosage forms.